The largest database of trusted experimental protocols

37 protocols using basic fgf

1

Friedreich's Ataxia iPSC Neurosphere Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human
Friedreich’s ataxia iPSC-derived neurospheres were grown in
Neurobasal-A medium with 2% B-27 supplement, 1% ITS-A supplement,
1% N-2 supplement, 2 mM glutamine, 1% antibiotic/antimycotic, 10 mM
HEPES, 20 ng/mL basic FGF, and 20 ng/mL EGF (R&D Systems) according
to a previous procedure.16 (link) Neurospheres
were dissociated to single cells with accutase and plated on Matrigel
(BDBiosciences) at 50,000 cells/cm2 and passaged every
4–5 days for expansion. Cells were centrifuged, and cell pellets
were collected and washed with PBS buffer.
+ Open protocol
+ Expand
2

hESC Culture and Isolation of Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Pluripotent Stem Cell Core at Einstein maintained WA-01 hESC (WiCell Foundation, Madison, WI) on irradiated feeder cells in DMEM/F12 medium with 20% knock-out serum replacer (KSR), 2mM l-glutamine, 0.1 mM MEM nonessential amino acids (NEAA), 1% penicillin-streptomycin (Invitrogen Corp., Carlsbad, CA), and 4 ng/ml basic FGF (R&D Systems, Minneapolis, MN) (complete medium). hESC-MEC were isolated from hESC cultured in DMEM with10% FBS, as described previously [29 (link),30 ]. FH-PP were sorted immunomagnetically for EpCAM and cultured to generate FH-P3, as described previously [31 (link)]. Cryo-preserved AH-PP were from Incara Pharmaceuticals (Raleigh-Durham, NC), and cultured as described previously [32 (link)].
+ Open protocol
+ Expand
3

Hepatocyte Differentiation for Metabolic Diseases

Check if the same lab product or an alternative is used in the 5 most similar protocols
HPCs from 5 pediatric patients (1 healthy donor and 4 different inborn metabolic liver diseases) and 4 adult healthy donors were generated by culturing PHHs in Dulbecco's modified Eagle's medium (DMEM)‐F12 Ham 15 mM 4‐(2‐hydroxyethyl)‐1‐piperazine ethanesulfonic acid (HEPES) with Na‐bicarbonate (Sigma), 1% glutamine, 1% penicillin/streptomycin, 1% NEAA, 10% Knockout‐Serum replacer (Gibco), 5% fetal bovine serum (FBS), 10 ng/mL EGF (Peprotech), 10 ng/mL basic FGF (R&D), and 3 μM CHIR99021 (Sigma). Cells were cultured on collagen I–coated plates and passaged weekly 1/6 with StemPro accutase (Gibco). Cell quantification was performed using the Countess Automated Cell Counter (Thermo‐Fisher) during cell expansion of 5 different donors (Crigler‐Najjar type 1 [CNI], citrullinemia [CIT], complement factor H deficiency, healthy donors 1 and 2). Hepatocyte dedifferentiation was performed more than 3 times for several samples. For cryopreservation, cells were frozen in DMEM‐F12 Ham 15 mM HEPES 10% Knockout‐Serum replacer, 5% FBS, and 10% dimethylsulfoxide (DMSO).
+ Open protocol
+ Expand
4

Isolation and Culture of Murine Myoblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiment protocols were approved by Institutional Animal Care and the Use Committee of University of Minnesota. Satellite cell-derived primary myoblasts such as CD31(−), CD45(−), Sca-1(−), and integrin α7(+) cells were isolated from skeletal muscles of 2 month-old mice (C57BL6, Charles River Laboratories, Wilmington, MA, USA) by MACS separation (Miltenyi Biotec, San Diego, CA, USA) as described previously (3 ). Myoblasts were maintained on collagen-coated dishes in growth medium (GM) (Ham’s/F10 [Sigma-Aldrich, St., Louis, MO, USA], 20% FBS, 20 ng/ml basic FGF [R&D Systems, Minneapolis, MN, USA] and 1% Penicillin/Streptomycin [Invitrogen, Carlsbad, CA, USA]) (7 (link)). Proliferating myoblasts in GM were defined as day 0. Then myogenic differentiation was caused by replacing GM with differentiation medium (DM) (DMEM [Sigma-Aldrich], 5% horse serum and 1% Penicillin/Streptomycin) for 3 days.
+ Open protocol
+ Expand
5

Differentiation of Endothelial Cells from Human Pluripotent Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human endothelial cells were generated as previously described7 (link). Maintenance and formation of EBs was performed as described in the paragraph cardiac differentiation. For induction of differentiation of mesodermal progenitor cells, EBs were cultivated in Pluronic F-127 (Sigma-Aldrich, P2443) -coated flasks in StemPro®-34 (Gibco 10639-011) supplemented with 4 mg/ml PVA; 400 µM 1-thioglycerol, Sigma-Aldrich M6145; 2 mM L-glutamin, Gibco 25030; 5 mg/L transferrin, Sigma-Aldrich T8158; 5 µg/L selenium, Sigma-Aldrich S5261; 0.5% Penicillin/Streptomycin, Gibco 15140; 10 µM Y-27632, biorbyt orb60104 and 10 ng/ml BMP-4, R&D Systems 314-BP; 6 ng/ml Activin-A, R&D systems 338-AC; 5 ng/ml basic FGF, R&D systems 233-FB for 3 days at 37 °C, 90% humidity, 5% CO2, 5% O2 with daily medium change. To differentiate endothelial cells, EBs were then cultured on Geltrex® in StemPro®-34, containing 400 µM 1-thioglycerol, Sigma-Aldrich M6145; 2 mM L-glutamin, Gibco 25030; 1 mM magnesium ascorbyl phosphate; 5 mg/L transferrin, Sigma-Aldrich T8158; 5 µg/L selenium, Sigma-Aldrich S52610.5% Penicillin/Streptomycin, Gibco 15140; 1 µM Y-27632, biorbyt orb60104; 100 ng/ml VEGF, R&D Systems 293-VE and 10 ng/ml bFGF, R&D Systems 233-FB. For 3 days, EBs were cultured in a hypoxic environment (5% CO2, 5% O2), followed by 9 days under normoxic conditions. Medium was changed every other day.
+ Open protocol
+ Expand
6

Cultivation of Glioma Stem Cells and Engineered MEFs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mycoplasma‐free patient‐derived glioma stem cells (h543 and h676) were cultured in neurosphere medium from NeuroCult (Stem Cell Technologies Inc, Vancouver, Canada) supplemented with 20 ng/ml basic‐FGF (RD Systems) and 10 ng/ml EGF (Gibco).
Mycoplasma‐free Trf1lox/loxp53−/− MEFs and K‐RasΔ/LG12Vgeop53−/− tumor‐derived CHA‐9‐3 cell line were cultured in DMEM supplemented with 10% fetal bovine serum (FBS). All cell lines and primary cultures were regularly tested mycoplasma‐free.
For retroviral infection, supernatants were produced in 293T cells transfected with the ecotropic packaging plasmid pCL‐Eco, the envelope plasmid pCMV‐VSV‐G and either pBabe‐Cre and/or EGFP‐TRF1 pWzl‐Hygro (a gift from T. de Lange, Addgene plasmid #19834) using Fugene transfection reagent. Two days later, retroviral supernatants were collected and Trf1lox/lox p53−/− MEFs were infected with the corresponding retroviral supernatant at 12‐h intervals.
For lentiviral infection, supernatants were produced in 293T cells transfected with the envelope plasmid pCMV‐VSV‐G, the ecotropic packaging plasmid psPAX2 and either pLKO.1 empty and/or pLKO.1 vectors expressing short hairpin RNA for either ERK1 or ERK2 (SIGMA) using Fugene transfection reagent. Two days later, lentiviral supernatants were collected and p53−/− MEFs were infected with the corresponding lentiviral supernatant at 12‐h intervals.
+ Open protocol
+ Expand
7

Culturing Human Embryonic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic stem cells (CHA4-hES line) (21 (link)) were maintained on a layer of mitomycin-C treated mouse embryonic fibroblasts (MEFs) in ESC medium in a humidified atmosphere of 5% CO2 in air. The ESC medium consisted of Dulbecco’s DMEM/F12 supplemented with 20% knockout serum replacement (Invitrogen, CA), 0.1 mM β-mercaptoethanol (Sigma-Aldrich, MO, USA), 1% non-essential amino acids (Invitrogen), 1% penicillin-streptomycin (Invitrogen), and 4 ng/ml basic FGF (R&D Systems, MN). For the feeder-free culture, hESCs were cultured on Matrigel (BD Biosciences, CA) in conditioned medium which was obtained by culturing mitomycin-C treated MEFs.
+ Open protocol
+ Expand
8

Maintaining Human Embryonic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human ESC line H1, obtained from WiCell (WA01), was maintained on 50 Gy irradiated (CF1) murine embryonic fibroblasts feeders, in DMEM/F12 medium (Invitrogen) containing 20% knockout serum replacement (Invitrogen), 0.5% penicillin/streptomycin (50 U/ml, Invitrogen), 1mM L-glutamine, 0.5% MEM non-essential amino acids (NEA, Invitrogen), 10 ng/ml basic FGF (R&D Systems), and 0.11mM BME (Invitrogen). hESCs were passaged weekly using 1mg/ml collagenase IV (Invitrogen) in DMEM/F12 for 10 minutes, detached by gentle pipetting or cell scraper to maintain cells in small clumps, washed twice and split to new 6-well plates containing irradiated CF1 MEFs. Cells were mycoplasma-tested and authenticated by short-term repeat analysis. hESC work was approved by the UCLA Embryonic Stem Cell Research Oversight committee. WA01 is not listed in the ICLAC or NCBI Biosample as commonly misidentified cell line.
+ Open protocol
+ Expand
9

Optimizing Cell Differentiation with Growth Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The isolated cells were divided into eight groups as follows: control group included cells without any treatment, FSH group included cells treated with 0.5 IU/ml human urinary FSH (Utrofol, Kuanart Pharmaceuticals, India), bFGFG group included cells treated with 100 ng/ml basic FGF (R&D Systems Inc, USA), NT3 group included cells treated with 100 ng/ml NT3 (R&D Systems Inc, USA), and other groups included cells treated with one of the combination of mentioned growth factors including FSH+NT3, FSH+ bFGF, NT3+bFGF, and FSH+NT3+bFGF. Each group included 3 same members (10000 cells). They were kept at 37°C in 5% CO
2
followed by monitoring by inverted microscope using Hoffman modulation contrast (Eclipse TE2000-S, Nikon, Japan). Cortical tissue sections were sampled on day three and RNA extraction was done after processing.
+ Open protocol
+ Expand
10

Differentiation of hiPSCs into Cerebrocortical Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
We differentiated hiPSCs used a standard protocol for generating cerebrocortical neurons (Talantova et al. 2013 (link)). Briefly, feeder-free hiPSCs were cultured on Matrigel in mTeSR 1 medium (StemCell Technologies) and induced to differentiate by a one week exposure to the following: A83–01, Dorsomorphin, and PNU74654 (each at 2 μM) in DMEM/F12 medium supplemented with 20% Knock Out Serum Replacement (Invitrogen). Next, PAX6+ neurospheres were formed by manually scraping cells and then maintained for 2 weeks in DMEM/F12 medium supplemented with N2 and B27 (Invitrogen) and 20 ng ml−1 of basic FGF (R&D Systems). Finally, the neurospheres were seeded on polyornithine/laminin-coated dishes to form rosettes and human neural progenitor cells (hNPCs) were manually picked and expanded. Terminal neuronal differentiation was accomplished by seeding at a 1:1 ratio with neonatal mouse astrocytes onto polyornithine/laminin-coated glass coverslips in DMEM/F12 medium supplemented with B27, N2, GDNF (20 ng ml−1) and BDNF (20 ng ml−1)(Peprotech), and 0.5% FBS (Invitrogen). Experiments were conducted after a total of 5–6 weeks of differentiation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!